Month: June 2025

Denifanstat met all primary and secondary endpoints versus placebo Denifanstat was well tolerated Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the U.S. SAN MATEO, Calif., June 04, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported denifanstat met all primary and secondary endpoints in a Phase 3 clinical trial for the treatment of moderate to severe acne vulgaris conducted by Sagimet’s license partner Ascletis Bioscience Co. Ltd. (Ascletis) in China. Denifanstat is a once-daily...

It is hereby announced that the IL Fund, as issuer of the bonds HFF150434 and HFF150644, has decided to exercise the right to settlement pursuant to item (i) of Article 7.A of the terms and conditions of the bonds, as provisionally adopted by resolution of the bondholders’ meeting held on 10 April 2025. The bonds settlement will take place on 12 June 2025, with payment for the notes to be made through the transfer of the assets specified in the resolution proposed at the meeting. Further information on the valuation of settlement assets will be published prior to settlement. Settlement will be made with the holders of the bonds as registered with the securities depository at the end of day 3 June 2025. Attention is drawn to the fact that in the event of a transfer of ownership after that date, these rights will not be transferred...

STOCKHOLM, SWEDEN, June 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has carried out a directed share issue through an accelerated bookbuilding procedure that brought the company approximately SEK 158 million. In connection with the directed share issue, the company announced an updated strategy and revised its financial targets for the period 2025–2028. Investors in the directed issue include both existing shareholders and new Swedish and international institutional investors such as Adrigo Asset Management, La financiere de L’Echiquier, Lancelot Asset Management AB, Linc AB and Tedde Jeansson through company. The subscription price in the directed issue was determined through an accelerated bookbuilding procedure. In connection with the directed share issue, the company announced...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1993, AS AMENDED (THE “SECURITIES ACT”)) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT. NANTERRE (FRANCE)JUNE 4, 2025 FORVIA SUCCESSFULLY PRICES AN ADDITIONAL EUR 250 MILLION OF SENIOR NOTES DUE 2030 FORVIA has successfully priced its offering of EUR 250 million in aggregate principal amount of additional senior notes due 2030 (the “New Notes”). FORVIA priced the...

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE REPURCHASE INVITATION WOULD BE PROHIBITED BY APPLICABLE LAW Worldline launches a repurchase invitation with respect to its outstanding OCEANE due July 2026 via a reverse bookbuilding Paris La Défense, June 4, 2025 – Worldline [Euronext: WLN], a global leader in payment services, today announces the launch of a repurchase invitation with respect to its existing bonds convertible into new shares and/or exchangeable for existing shares maturing in July 2026 via a reverse bookbuilding. On 3rd June , Worldline successfully placed a €550 million bond maturing in June 2030 to be issued under its EMTN Programme. The net proceeds of the issue will be applied by Worldline...

Orders Placed for Key Long Lead Items TMG Engaged to Provide Project Management Services VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its 100% owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to provide a project update. The Company has placed long lead item orders for two winders and has engaged Technical Management Group Ltd (“TMG”) to provide project management consulting services for the development of South Crofty. Winder Orders Orders have been placed with Qualter Hall & Company Limited (“Qualter Hall”) for the design, manufacture, supply, installation and commissioning of the production and service winders to be...

ATHENS, Greece, June 04, 2025 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (“Performance Shipping” or the “Company”), through its Norwegian investment banks, will arrange a series of fixed income investor calls commencing on June 6, 2025. A five-year USD denominated senior unsecured bond issue may follow, subject to inter alia market conditions. The net proceeds from the contemplated bond issue shall be applied towards fleet expansion and renewal and general corporate purposes of the Company. The senior unsecured bonds, if issued, will be offered in the United States or its territories only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “U.S. Securities Act”), and sold outside the United States only to non-U.S. persons...

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers the same efficacy and safety demonstrated in available oral solution Evrysdi is the only non-invasive disease-modifying SMA treatment, with more than 18,000 people with SMA treated globally to dateBasel, 04 June 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature stable tablet for people living with spinal muscular atrophy (SMA). The 5mg tablet (approx. 6.5mm), which can either be swallowed whole or dispersed in water, can be taken with or without food and does not require refrigeration, when stored at room temperature. Administered at home, Evrysdi is the...

Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Combined General Meeting (“the Meeting”) to be held on June 25, 2025 at 2:00 p.m. CEST at the Sofitel Lyon Bellecour Hotel, 20 quai du Docteur Gailleton, 69002 Lyon (France). The Preliminary Notice of Meeting – including the agenda, the draft resolutions proposed by the Board of Directors, and instructions for participation and voting to the Meeting – was published in the Bulletin des Annonces Légales Obligatoires (BALO) on May 21, 2025. The information and preparatory documents related to this Meeting are available on Valneva’s website via this Link. Any shareholder wishing to receive, by mail or e-mail, Meeting documents referred to in Article...

WISeKey International Holding Ltd Announces Adjournment of 2025 Annual General Meeting Zug, Switzerland, June 4, 2025 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), leading global cybersecurity, blockchain, and IoT company, announced today that the Board of Directors has decided, for logistical reasons, to ajourn the 2025 Annual General Meeting of Shareholders (“AGM“) from June 19, 2025, 2:00 p.m. Swiss time, to June 27, 2025, at 2:00 p.m. Swiss time. The venue of the 2025 AGM will remain the offices of Homburger AG, Prime Tower, Hardstrasse 201, 8005 Zurich, Switzerland. Admittance to the 2025 AGM will start at 1:30 p.m. Swiss time. Other than the date of the AGM, nothing will change. In particular, the items on the agenda of...